SCHEMBL408318

SCHEMBL408318

O=C(c1ccccc1)C1CCNCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.66
MEN1 O00255 2/20 0.66
CYP2D6 P10635 1/20 0.66
HTR3E A5X5Y0 1/20 0.53
HTR3B O95264 1/20 0.53
HTR3A P46098 1/20 0.53
HTR3D Q70Z44 1/20 0.53
HTR3C Q8WXA8 1/20 0.53
MGLL Q99685 2/20 0.50
GABRP O00591 1/20 0.50
GABRD O14764 1/20 0.50
GABRA1 P14867 1/20 0.50
TSHR P16473 1/20 0.50
GABRB1 P18505 1/20 0.50
GABRG2 P18507 1/20 0.50
GABRB3 P28472 1/20 0.50
GABRA5 P31644 1/20 0.50
GABRA3 P34903 1/20 0.50
GABRA2 P47869 1/20 0.50
GABRB2 P47870 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL10968790 0.98 KMT2A (0.64) KMT2AMEN1CYP2D6HTR3EHTR3B
Hydrochloric Acid SCHEMBL227939 0.98 KMT2A (0.69) KMT2AMEN1CYP2D6HTR3EHTR3B
Hydrochloric Acid SCHEMBL656874 0.96 KMT2A (0.62) KMT2AMEN1CYP2D6HTR3EHTR3B
SCHEMBL4674654 0.89 MEN1 (0.63) KMT2AMEN1CYP2D6HTR3EHTR3B
SCHEMBL407286 0.89 KMT2A (0.53) KMT2AMEN1CYP2D6HTR3EHTR3B
Hydrochloric Acid SCHEMBL440964 0.87 KMT2A (0.56) KMT2AMEN1CYP2D6HTR3EHTR3B
SCHEMBL13944266 0.86 MEN1 (0.69) KMT2AMEN1CYP2D6HTR3EHTR3B
SCHEMBL18428493 0.85 HTR2A (0.56) KMT2AMEN1MGLLHTR2ACPB1
SCHEMBL324342 0.85 HTR2A (0.56) KMT2AMEN1MGLLHTR2ACPB1
SCHEMBL4675888 0.85 MEN1 (0.58) KMT2AMEN1CYP2D6MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 602 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118561742-A Rupestonic acid amide derivative containing nitrogen heterocycle, and preparation method and application thereof 中国科学院新疆理化技术研究所 2024-08-30 CN claimed
CN-108069956-B 1-azabicyclo [2,2,2] oct-4-yl phenyl ketone compound, preparation method and application thereof 扬州奥锐特药业有限公司 2021-03-16 CN claimed
CN-108069956-A 1- azabicyclos [2,2,2] octyl- 4- base phenyl ketone compounds and its preparation method and application 扬州奥锐特药业有限公司 2018-05-25 CN claimed
EP-1153013-B1 5-HT1F AGONISTS LILLY CO ELI (US) 2007-10-31 EP claimed
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US claimed
EP-1401821-A4 NOVEL PHENYLALKYL DIAMINE AND AMIDE ANALOGS SK CORP (KR) 2006-05-31 EP claimed
EP-0489085-B1 RIGID-ROD POLYMERS MISSISSIPPI POLYMER TECHNOLOGI (US) 2005-12-07 EP claimed
CN-1572299-A Medicine for improving excretion capacity of bladder TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2005-02-02 CN claimed
CN-1547575-A Novel phenylalkyldiamine and amide analogs SK��ʽ���� 2004-11-17 CN claimed
EP-1401821-A1 NOVEL PHENYLALKYL DIAMINE AND AMIDE ANALOGS SK Corporation (KR) 2004-03-31 EP claimed
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-06-05 US claimed
WO-2002100848-A1 NOVEL PHENYLALKYL DIAMINE AND AMIDE ANALOGS SK CORPORATION (KR) 2002-12-19 WO claimed
EP-0489085-A4 RIGID-ROD POLYMERS MAXDEM INC (US) 1992-08-05 EP claimed
EP-0489085-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1992-06-10 EP claimed
WO-1991002764-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1991-03-07 WO claimed
EP-0202164-B1 (BENZOYL-4-PIPERIDINO)-2-PHENYL-1-ALKANOL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES SYNTHELABO (FR) 1989-02-08 EP claimed
EP-0014295-B1 BENZODIOXAN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTICAL APPLICATIONS Bouchara, Emile Dr. (FR) 1983-01-19 EP claimed
EP-0014295-A1 Benzodioxan derivatives, process for their preparation and their therapeutical applications Bouchara, Emile Dr. (FR) 1980-08-20 EP claimed
JP-1045384-A None JP disclosed
US-3968217-A ANTIDEPRESSANT A. H. ROBINS COMPANY, INCORPORATED (US) 1976-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SIGMAR1, TAAR1, OPRL1 KMT2A 1375/4885MEN1 4634/4885CYP2D6 1103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.